HSBC to privatise Hang Seng Bank in surprise bid for efficiency amid real estate loan woes

Core Viewpoint - HSBC plans to privatise Hang Seng Bank, which will cost approximately HK$106.16 billion (US$13.64 billion) in cash payouts, marking the end of the bank's publicly traded status after nearly 50 years [1][6]. Company Overview - Hang Seng Bank was acquired by HSBC in 1965, with HSBC gradually increasing its ownership to nearly 63% from an initial 51% [2]. - The bank was listed on the Hong Kong stock exchange in 1972 and has a rich history dating back to its establishment in 1933 [2][3]. Privatization Details - HSBC will buy all outstanding shares of Hang Seng Bank for HK$155 each, representing a 30% premium over the stock's closing price of HK$119 prior to the announcement [5][6]. - The shares of Hang Seng Bank will be cancelled post-purchase, and the bank will retain its brand, branch network, and board structure [3][5]. Strategic Rationale - The privatisation is seen as a long-term strategic investment aimed at enhancing capital management and operational efficiency under HSBC's umbrella [5][12]. - HSBC's CEO emphasized that the move would simplify the organisational structure and decision-making processes, allowing for more agile operations [14][15]. Financial Context - Hang Seng Bank has faced challenges, including an 85% increase in impaired real estate loans, which reached HK$25 billion as of June, contributing to a decline in its first-half profit to HK$6.88 billion [10][13]. - The bank's capitalisation remains strong, with a common equity Tier 1 (CET1) ratio of about 21%, indicating resilience despite credit challenges [13]. Market Reaction - Following the announcement, Hang Seng Bank's shares surged by as much as 41% during intraday trading, while HSBC's shares fell by 5.7% [6][7]. Regulatory and Advisory Aspects - BofA Securities and Goldman Sachs are acting as joint financial advisers for the privatisation, and the Hong Kong Monetary Authority is aware of the proposed changes and is in communication regarding regulatory approvals [17].